搜索到 1000 条关于 77c문발카지노디비상담♣텔레DaisoDBlㄱ 的文章
-
2013.12.11 T2DM患者使用非诺贝特应谨慎
研究要点:同时接受非诺贝特和噻唑烷二酮类(TZD)治疗的T2DM患者,HDL-C水平显著降低极低HDL-C的发生可能与非诺贝特和TZD同时使用有关为了测定控制糖尿病心血管疾病风险行动(ACCORD)脂质试验中参与者极低HDL-C的发生情况,并对极低HDL-C
-
2012.09.19 16th Congress of the Asian Pacific Society of Respirology


16th Congress of the Asian Pacific Society of Respirology
3 – 6 November, 2011, Shanghai
www.apsr2011.orgWelcome message from the Honorary Congress PresidentOn behalf of the Local Congress Committee, it is my honor to cordially invite you all to the 16th APSR. In its 16th year, the APSR Congress has been welcomed for the third time to China and we consider it a great honor to host this event, for the first time in Shanghai. The Congress venue will be the Shanghai International Convention Center. The APSR, Chinese Society of Respiratory Diseases and Shanghai Medical Association have joined forces as co-organizers of the Congress to bring together physicians, academics, healthcare professionals and decision makers in the field of respiratory medicine from around the world to discuss emerging issues and exchange ideas on current research and clinical topics in respirology.The Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in respirology, primarily in conditions commonly found in the Asia Pacific region. The meeting will invite many distinguished international speakers who are expected to participate and provide insights and expert opinion on a wide range of topics in pulmonary and respiratory medicine.I hope that you will enjoy the Congress and that your interaction with your colleagues from different countries will stimulate a creative exchange of ideas and will be personally rewarding. I also trust that you will enjoy your visit to the beautiful and exciting city of Shanghai, in November 2011.

Prof. Zhong Nanshan
Honorary Congress President, APSR 2011
Welcome message from the Congress PresidentIt is my great pleasure and honor as Congress President, to welcome you to the 16th Congress of the Asian Pacific Society of Respirology (APSR). The APSR is renowned as a dynamic organization showcasing the breadth and depth of respiratory medicine across the Asia Pacific region. Following the success of the two previous meetings held in China, this year’s congress hosted by Chinese Society of Respiratory Diseases (CSRD) and Shanghai Medical Association, will be held at the Shanghai International Convention Center, in the vibrant and international metropolis of Shanghai. Since its inception and first meeting held in Tokyo in 1988, the congress has gone from strength to strength and we are expecting this year’s meeting to be no exception and continue this momentum to be an outstanding success.Scheduled for the 3 – 6 November 2011, this four-day congress will feature a comprehensive scientific program, including post-graduate courses, lectures and symposia conducted by key note speakers, who are experts in the field of respirology. In addition, oral and poster presentations will provide exposure for researchers, as a platform for academic exchange on exciting new topics currently under investigation. The organizing committee has organized a range of social events and tours to encourage participants to experience the diverse local culture and traditions of the host city.I hope this Congress will be an exciting and productive gathering of respirologists from the Asia Pacific Region and provide an opportunity to share their knowledge, experience and views on current respiratory disease topics, and provide a platform for networking and collaboration between academics and physicians across the region.I would like to thank the APSR 2011 Local Congress Committee for their dedication and support in making this Congress a success and I would also like to thank all participants for their continued interest and involvement in these meetings and look forward to meeting you in November in Shanghai.We invite you to visit the website (www.apsr2011.org) regularly for the latest updates and news about the organization of the Congress.See you in Shanghai in 2011

Prof. Bai Chunxue
Congress President, APSR 2011
-
-
2014.07.28 升高HDL胆固醇类药物并没有实际治疗收益
在血脂调控领域始终有一个缺乏说服力的假设——贝特类、烟酸和胆甾醇酯转运蛋白(CETP)阻滞剂等药物可以通过升高HDL胆固醇(HDL-C)水平达到降低患者心血管疾病(CV)事件的作用。但是近期一项由Matthew Shun-Shin博士带领开展的meta分析却再次向这种假设提出了质疑,他们发现这些升HDL-C药物并不能
-
-
2013.04.30 膝关节置换术后的膝盖皮肤温度与血清IL-6,C-反应蛋白,红细胞沉积速率的关系的前瞻性研究
膝关节置换术后的膝盖皮肤温度与血清IL-6,C-反应蛋白,红细胞沉积速率的关系的前瞻性研究 ... by monitoring serum interleukin-6 (IL-6), C-reactive protein (CRP), erythrocyte
-
-
2014.05.17 高胆固醇血症患者的联合降脂治疗
,使低密度脂蛋白胆固醇(LDL-C)水平降低≥50%,另外一些国家的指南推荐根据ASCVD风险水平确定LDL-C治疗目标值(<100mg/dL或<70mg/dL)。但是,许多接受中等或高强度他汀治疗的患者,LDL-C未能达标。因此,对于这类患者,推荐联合非他汀药物进一步降低LDL-C水平。2期
-
-
2014.12.08 FDA 更新妊娠及哺乳期用药等级标签规则
妊娠期间处方药使用风险的字母分类 -A、B、C、D 及 X,该三个部分描述了可能需要药物治疗的妊娠妇女在真实医护环境下的风险。
-
-
2012.12.10 2010年SHEA、IDSA成年人艰难梭菌感染临床诊治指南
for C. difficile toxins or toxigenic C. difficile, or colonoscopic
-
-
2016.06.15 贾伟平教授:国内外 T2DM 易感基因差异大--我国 T2DM 诊断 HbA1c 最佳切点为 6.3%
预测模型。研究发现该模型对糖尿病的早期预防有很大帮助。中国人群糖尿病诊断有别于外国:HbA1c 6.3% 切点优于 6.5%不止易感基因方面我国与国外有种族差异...。并且 OGTT 在临床的实际使用情况只是属于小众,执行标准也不够规范。WHO 提出,在 OGTT 实行困难的情况下,可使用 HbA1c 来诊断糖尿病。美国 ADA
-
2012.06.25 阿贝西普对有发展成1型糖尿病风险的人群可能具有潜在的预防作用
纳入112例受试者,年龄6至36岁,均最近被诊断患有1型糖尿病。这些参与者中,77例2年内接受静脉输注阿贝西普治疗27次,35例接受安慰剂治疗。结果发现阿贝西普...对患者进行长达1年随访研究。结果发现,停止阿贝西普治疗后1年,对患者年龄和基线水平进行校正后,阿贝西普治疗组患者C-肽水平平均为0.215 pmol/mL(95
-
-
2014.10.24 关节镜下前交叉韧带重建术后感染监测
甚理想。在临床实际工作中,医生在对感染进行诊断时常常需要对C反应蛋白和血沉进行监测,因为这两种指标可用于诊断感染,还可以对感染治疗的效果进行监测。然而,因为前交叉韧带重建术后感染的发生率很低,尚未见到大宗病例的相关报道,并且C反应蛋白和血沉用于诊断和监测感染的界值也仍不明确。来自北京大学第三医院运动医学研究所的王成和敖
-
-
2017.07.25 常用六种他汀类药物有何异同?
方面有哪些共同点?在药动学结构特点方面有哪些差异?哪些药物半衰期较长?上述前六种他汀类药物降低 LDL-C 的幅度有何差异?参考答案他汀类药物的共同点1. 药理作用:他汀类药物通过抑制体内胆固醇合成过程中的羟甲戊二酰辅酶(AMG-CoA)还原酶,促进低密度脂蛋白(LDL)的代谢和增加高密度脂蛋白(HDL-C
-
-
2012.04.26 如何分析糖耐量试验
end-37衡量B细胞的功能要分析以下几点-19end-38纠正错误概念-18如何分析糖耐量试验-1如何分析胰岛素及C肽分泌曲线-15胰岛素(C肽)释放曲线的非量化标准的分析-17异常OGTT-6胰岛素抵抗公式-16异常OGTT-7异常OGTT-8异常OGTT-9
-
-
2017.02.08 t(8;21) 染色体异常的 AML:氟达拉滨+阿糖胞苷优于单药
复发,含高剂量阿糖胞苷(HD-Ara-C,high-dose cytarabine)的化疗方案可治愈 50%~60% 存在 t(8;21)染色体异常的 AML 患者。很多预后因素与高复发风险相关,如年龄、高白细胞血症、其他细胞遗传学异常、基因突变如 c-kit 和 FLT3-ITD、微小残留病(MRD)等。为了评估
-
-
2013.02.18 刘建坤:颈椎病的诊断与治疗
Luschka关节的解剖特点-32C3-C5-33TCD频谱的有关参数-61...要点-73颈椎病流行病学-6颈椎病的治疗原则-77颈椎病流行病学-7
